RLRokos Capital Management LLP

Institutional investor · Portfolio as of Q2 2020

SEC EDGAR SourceSEC Filings

Top Holdings10 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
BABABABA
CALL

ALIBABA GROUP HOLDING-SP ADR

3.2M$680.5M34.2%
New
BABABABA
ADR

ALIBABA GROUP HOLDING-SP ADR

2.3M$491.2M24.7%$202.990.00%
1 qtr
New
100
EMBEMB
PUT

ISHARES TR

3.5M$376.8M18.9%
New
XLUXLU
ETF

UTILITIES SELECT SECTOR SPDR

3M$168.6M8.5%$23.89-0.66%
2 qtrssince 2020-Q1
Increased
98
XLVXLV
CALL

HEALTH CARE SELECT SECTOR SPDR

538,000$53.1M2.7%
Unchanged
XLVXLV
PUT

HEALTH CARE SELECT SECTOR SPDR

538,000$53.1M2.7%
Unchanged
XLPXLP
ETF

CONSUMER STAPLES SPDR

903,568$52.9M2.7%$50.47-0.30%
3 qtrssince 2019-Q4
Increased
84
XLYXLY
CALL

CONSUMER DISCRETIONARY SELT

410,000$52.1M2.6%
Unchanged
XLYXLY
PUT

CONSUMER DISCRETIONARY SELT

410,000$52.1M2.6%
Unchanged
DADADADADelisted
ADR

DADA NEXUS LTD

516,276$11.4M0.6%
1 qtr
New
57
$2B
AUM
10
Positions
Q2 2020
Filing
Rating · 1.0
Quarterly Portfolio Change
+234%Q1'19$121.5M+38%Q3'19$167.8M
Activity profile
$ moved · Q2'20
New58%Increased6%Decreased0%Exited36%
Composition
Equity vs derivatives
Equity36%Puts24%Calls39%
Holding period
Avg <1 quarter
<1Q40%1-4Q60%1-2Y0%2Y+0%

Rokos Capital Management LLP manages $2B across 10 positions as of Q2 2020. Top holdings: BABA (34.2%), BABA (24.7%), EMB (18.9%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 1/5.0.

Q2 2020 Summary

Added 2 new positions, increased 2. Top move: BABA (NEW, conviction 100). Portfolio: $2.0B across 10 positions.

Top holdings by portfolio weight

Total AUM$724M
BABA24.66%
XLU8.46%
XLP2.66%
DADA0.57%

Portfolio allocation by GICS sector

Sectors2
Consumer Cyclical67.84%
Unknown32.16%

Behavioral investing profile

Checking access…
Momentum Trader- primarily Consumer Cyclical, Unknown
Compare DNA across all funds
7-dimension quality assessment
Weak(1.0 / 5.0)
Track Record37
Conviction46
Concentration31
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Top Losers

Checking access…

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
3Q
NSCNSCNORFOLK SOUTHERN CORP
Q4 2025 Q2 2026+257,003 shares+$81.6M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used